Max Melchers

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial

Yaseen M. Arabi, Anthony Gordon, Lennie Derde et al. · Intensive Care Medicine · 2021 · 100 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021

Jochem B. Buil, Arthur R. H. van Zanten, Robbert G. Bentvelsen et al. · Eurosurveillance · 2021 · 74 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study

Max Melchers, Arthur R. H. van Zanten, Moniek Heusinkveld et al. · Critical Care Explorations · 2022 · 17 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study

Max Melchers, Vivienne de Smet, Chrissie Rooijakkers et al. · Annals of Intensive Care · 2025 · 13 citations · Full text

Medicine, Pharmacotherapy, Hemodynamic Management +16